The Government has defended the Cass Review as the “most comprehensive assessment” of gender confusion in young people, rejecting calls to re-examine the report’s findings.
A petition had called for an ‘independent evaluation’, but in response, the Department of Health and Social Care said instead that the Government and NHS England are “fully committed to implementing all recommendations” from the Cass Review.
Last year, Dr Hilary Cass criticised activists for deliberately trying to undermine her review with “misinformation” about its methodology.
‘Evidence-based’
The Department stated: “The government is clear that healthcare provision for children and young people experiencing gender dysphoria and incongruence must be safe, evidence-based and clinically appropriate. Implementing the Cass Review ensures that this will happen.
“The government does not, therefore, believe an independent evaluation of the Cass Review would be beneficial and there are no plans for an independent evaluation.”
The petition claims the review has “led to restrictive practices that are being directly felt by transgender children”.
Puberty blockers
In December, a UK-wide ban on the sale or supply of puberty-blocking drugs to gender-confused children was extended ‘indefinitely’.
Announcing the end to existing temporary measures, Health Secretary Wes Streeting said the decision was based on evidence that ‘the current prescribing pathway’ poses an “unacceptable safety risk” to children and young people.
The use of puberty blockers has been discredited by the Cass Review, which found they offer no known improvements to gender-confused children’s mental health, but adversely affect bone density and brain development.
Doctor alleged to have coerced girl into sex-change surgery faces trial
GPs branded ‘transphobes’ for refusing to prescribe ‘sex-swap’ hormones
Puberty blocker study was withheld ‘because data didn’t back trans agenda’